METLIFE, INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$23.81B
↑+27.6% +$5.15Bvs FY2024 (Q4)
Gross Profit
$7.04B
↑+15.5% +$944Mvs FY2024 (Q4)
Operating Income
$1.68B
↑+12.6% +$188Mvs FY2024 (Q4)
Net Income
$809M
↓-36.3% -$462Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $23.81B | $18.67B |
| COGS | $16.78B | $12.57B |
| Gross Profit | $7.04B | $6.09B |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $30M | $33M |
| Other OpEx | $5.33B | $4.57B |
| Operating Income | $1.68B | $1.49B |
| Interest Exp. | $562M | $110M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $1.12B | $1.38B |
| Tax | $308M | $110M |
| Net Income | $809M | $1.27B |
QuarterCharts · SEC EDGAR data · MET · Comparing FY2025 (Q4) vs FY2024 (Q4)